Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability: Clinical Practice Data from a Multicenter Italian Cohort

Dolutegravir (DTG) is currently one of the most used Integrase inhibitors (INI) in antiretroviral therapies (ARV) in both naïve and experienced people living with HIV (PLWHIV). We analyzed a multicenter cohort of PLWHIV, both naïve and experienced, starting an ARV including DTG. We enrolled 3775 PLW...

Полное описание

Библиографические подробности

Главные авторы:	Arturo Ciccullo, Gianmaria Baldin, Vanni Borghi, Filippo Lagi, Alessandra Latini, Gabriella d’Ettorre, Letizia Oreni, Paolo Fusco, Amedeo Capetti, Massimiliano Fabbiani, Andrea Giacomelli, Alessandro Grimaldi, Giordano Madeddu, Gaetana Sterrantino, Cristina Mussini, Simona Di Giambenedetto
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2022-01-01
Серии:	Viruses
Предметы:	HIV HAART dolutegravir toxicity
Online-ссылка:	https://www.mdpi.com/1999-4915/14/1/163
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!